Sofiva Genomics Co.,Ltd. (TPEX:6615)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
34.05
+0.05 (0.15%)
Jul 21, 2026, 1:17 PM CST
Market Cap734.18M +4.9%
Revenue (ttm)382.82M -10.6%
Net Income8.39M +211.1%
EPS0.39 +210.3%
Shares Out 21.59M
PE Ratio87.53
Forward PEn/a
Dividend0.30 (0.88%)
Ex-Dividend DateJun 27, 2025
Volume9,742
Open34.90
Previous Close34.00
Day's Range34.00 - 34.90
52-Week Range28.90 - 40.00
Beta0.19
Analystsn/a
Price Targetn/a
Earnings DateAug 12, 2026

About Sofiva Genomics

Sofiva Genomics Co.,Ltd. provides pre-pregnancy, prenatal, and newborn genetic testing and medical testing services in Taiwan and internationally. The company offers reproductive testing services, including preimplantation genetic testing for aneuploidy (PGT-A), non-invasive preimplantation genetic testing for aneuploidy (niPGT-A), and preimplantation genetic testing for monogenic diseases (PGT-M); and prenatal testing services, such as non-invasive prenatal screening, array, karyotyping, maternal serum screening for down syndrome, risk assessm... [Read more]

Sector Healthcare
Founded 2012
Employees 104
Stock Exchange Taipei Exchange
Ticker Symbol 6615
Full Company Profile

Financial Performance

Financial Statements